Clinical Trials Logo

Diabetic Foot clinical trials

View clinical trials related to Diabetic Foot.

Filter by:

NCT ID: NCT03110796 Recruiting - Diabetic Foot Ulcer Clinical Trials

Assessment of the Efficacy and Safety of a New Medical Device in the Local Treatment of Diabetic Foot Ulcers

DISCOVERY
Start date: July 31, 2017
Phase: N/A
Study type: Interventional

Evaluation of the efficacy and safety of a device with LU3103209 compound versus the same device, free of LU3103209 compound, in the local management of DFUs.

NCT ID: NCT03089463 Suspended - Diabetes Clinical Trials

Foot Assessment in People With Diabetes: A Quantitative Diagnostic Approach

Start date: November 27, 2017
Phase:
Study type: Observational

This observational cohort study aims to develop a novel risk stratification system implementing biomechanics to aid in the prevention of diabetic foot ulcers.

NCT ID: NCT03088566 Completed - Diabetic Foot Clinical Trials

Implementation of the D-Foot at the Department of Prosthetics and Orthotics

Start date: August 15, 2017
Phase: N/A
Study type: Interventional

Early identification of potential risk factors for the onset of diabetic foot ulcers are recommended. However, in a Swedish context, there has been no standardised routines to be used in the foot screening procedure. In this study a new standardised routine, the D-Foot, will be tested at the Department of Prosthetics and Orthotics. The usability of the web program will be tested.

NCT ID: NCT03078933 Recruiting - Diabetic Foot Ulcer Clinical Trials

A Feasibility Study of Advance Plasma Therapy001 Plasma/Nitric Oxide Therapy for the Treatment of Diabetic Foot Ulcers

Start date: March 20, 2017
Phase: N/A
Study type: Interventional

The clinical trial will assess the delivery of Nitric Oxide topically to the diabetic foot ulcer wound and the surrounding wound area as it related to wound healing. The objective of the study is to assess the Nitric Oxide Therapy treatment time (the number of minutes to deliver the treatment) and frequency (number of days per week to treat) to determine the most optimal treatment time and frequency to develop a rationale for safety and efficacy for the final APT001 clinical study.

NCT ID: NCT03069729 Completed - Clinical trials for Diabetic Retinopathy

Thermal Screening for Early Diabetic Peripheral Neuropathy (DPN)

Start date: March 8, 2017
Phase:
Study type: Observational

The goal of this research is to develop better tools for diagnosing illness of the feet and legs of people who have diabetes. Investigators will use thermal videos of the foot to aid in the refinement of a system designed to detect signs of diabetic peripheral neuropathy (DPN). The team of investigators will also look at diabetic eye disease and how it might relate to diabetic foot disease.

NCT ID: NCT03063138 Completed - Diabetes Mellitus Clinical Trials

Evaluation of 3D Imaging Ulcer Camera

3D-DFU
Start date: August 1, 2015
Phase: N/A
Study type: Observational

The aim of the study is to evaluate the intra- and inter-rater variability of wound measurements using the 3D camera and to compare with standard measurement methods (2D image method and gel injection). Forty-eight patients with wounds of various sizes are measured by four clinicians. Each wound is measured twice with the 3D camera, once by 2D image method and once by gel injection into wound cavity by two clinicians.

NCT ID: NCT03044132 Completed - Diabetic Foot Ulcer Clinical Trials

DermACELL AWM® in Chronic Wagner Grade 3/4 Diabetic Foot Ulcers

Start date: January 15, 2017
Phase: N/A
Study type: Interventional

This is a prospective, multicenter, clinical research trial evaluating the clinical outcomes of DermACELL AWM in dermal regeneration.

NCT ID: NCT03041844 Active, not recruiting - Diabetic Foot Ulcer Clinical Trials

Enhanced Ultrasound Treatment of Chronic Wounds With Monitoring of Healing and Quality of Life Outcomes

Start date: January 2017
Phase: N/A
Study type: Interventional

The purpose of this study is to evaluate the effect of low frequency, low intensity ultrasound treatment on wound healing and health-related quality of life with a randomized clinical trial of patients with venous ulcers or diabetic ulcers.

NCT ID: NCT03037970 Recruiting - Clinical trials for Diabetic Foot Ulcers

Evaluation of ABSOLVE in Diabetic Foot Ulcers

ABSOLVE
Start date: January 30, 2017
Phase: Phase 2
Study type: Interventional

ABSOLVE Biologic Wound Matrix is a combination of recombinant human platelet-derived growth factor BB homodimer (rhPDGF-BB) and a bovine type I collagen wound dressing matrix. ABSOLVE is under development for the treatment of chronic and acute wounds. This study investigates the safety and efficacy of ABSOLVE in chronic diabetic foot ulcers (DFUs).

NCT ID: NCT03021811 Completed - Diabetic Foot Ulcer Clinical Trials

EUREKA Italy - Evaluation of Real-life Use of KLOX BioPhotonic System in Chronic Wounds Management

Start date: October 2015
Phase: N/A
Study type: Interventional

Multi-center, prospective, interventional, uncontrolled open-label study evaluating the real-life use of KLOX LumiHeal BioPhotonic System in chronic wounds management (venous leg ulcers, diabetic foot ulcers, pressure ulcers).